Irritable Bowel Syndrome

Irritable Bowel Syndrome
Irritable bowel syndrome (IBS, or spastic colon) is a symptom-based diagnosis characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits. As a functional bowel disorder, IBS has no known organic cause. Diarrhea or constipation may predominate, or they may alternate. Although there is no cure for IBS, there are treatments that attempt to relieve symptoms, including dietary adjustments, medication and psychological interventions.
  • Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases.
  • Home to a diverse range of microorganisms, a healthy human body contains at least tenfold more bacteria cells than human cells. The most abundant and diverse microbial community resides in the intestine, and changes to the gut microbiota are linked with diseases such as ulcerative colitis and Crohn's disease. In a report published online today in Genome Research(, researchers have analyzed the long-term effects of gut bacterial transplantation in rats, revealing crucial insight that will aid in the development of new treatments.
  • Irritable bowel syndrome (IBS) is a common problem with the intestines. IBS is a health problem that is often ignored and whose real cause is yet to be found.
  • Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (NDA) for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non–constipation irritable bowel syndrome (Non–C IBS) and IBS–related bloating.
  • People aged over 50 are at a higher risk of contacting the inflammatory intestinal disease ulcerative colitis remission compared to youngsters who suffered the diseases, according to data provided by a new study conducted in the United States.